[Quinolone-resistant mutations in Neisseria gonorrhoeae]. 1995

S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
Department of Urology, Jikei University School of Medicine, Tokyo, Japan.

For 10 strains of Neisseria gonorrhoeae exhibiting decreased susceptibility to new quinolones (MIC, > or = 0.1 microgram/ml) isolated and preserved from patients with gonococcal urethritis during the period from February 1991 through January 1992. We investigated the mechanisms for development of resistance to new quinolones. After selecting 3 PCG-sensitive and new quinolone-resistant strains from among these strains, we first carried out transformation experiments of N. gonorrhoeae using a plasmid carrying the E. coli gyrA gene. We then determined the base sequence on the N. gonorrhoeae gyrA gene by PCR method. Of the 3 strains in which transformation experiments were carried out, 2 strains yielded transformants, one of which was 8 times more sensitive to norfloxacin (NFLX) than the original strain, and it was assumed that this strain has a mutation in the gyrA gene. In our study of the base sequence on the N. gonorrhoeae gyrA gene using the PCR method, both strains had the mutation of Ser 83 (TCC)-->Phe (TTC), and in addition to this mutation of Ser-->Phe, one other strain had the mutation of Asp-87 (GAC)-->Gly (GGC). This type of mutation of quinolone-resistant N. gonorrhoeae on the gyrA gene has high homology with the mutations reported for Escherichia coli and other strains and there appears to be a close correlation between the increasing frequency of use of the new quinolones in this country and the spread of such resistant strains of N. gonorrhoeae.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009344 Neisseria gonorrhoeae A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA. Diplococcus gonorrhoeae,Gonococcus,Gonococcus neisseri,Merismopedia gonorrhoeae,Micrococcus der gonorrhoe,Micrococcus gonococcus,Micrococcus gonorrhoeae
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D006069 Gonorrhea Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879. Neisseria gonorrhoeae Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014526 Urethritis Inflammation involving the URETHRA. Similar to CYSTITIS, clinical symptoms range from vague discomfort to painful urination (DYSURIA), urethral discharge, or both. Urethritides
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
December 2005, International journal of STD & AIDS,
S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
February 1995, Antimicrobial agents and chemotherapy,
S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
June 1996, Journal of clinical microbiology,
S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
January 1996, Sexually transmitted diseases,
S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
October 1999, Fukuoka igaku zasshi = Hukuoka acta medica,
S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
January 2006, International journal of STD & AIDS,
S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
September 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
January 1991, Journal of medical microbiology,
S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
December 2012, International journal of antimicrobial agents,
S Onodera, and K Kishimoto, and H Kiyota, and H Goto, and H Igarashi, and M Kawahara, and Y Oishi, and T Okazaki, and H Yoshida
April 2001, Current infectious disease reports,
Copied contents to your clipboard!